Biosensors (Feb 2023)

Nanobody-Based Sandwich Immunoassay for Pathogenic <em>Escherichia coli</em> F17 Strain Detection

  • Asma Dhehibi,
  • Abdelmounaaim Allaoui,
  • Amal Raouafi,
  • Mohammed Terrak,
  • Balkiss Bouhaouala-Zahar,
  • Mohamed Hammadi,
  • Noureddine Raouafi,
  • Imed Salhi

DOI
https://doi.org/10.3390/bios13020299
Journal volume & issue
Vol. 13, no. 2
p. 299

Abstract

Read online

Rapid and specific detection of pathogenic bacteria in fecal samples is of critical importance for the diagnosis of neonatal diarrhea in veterinary clinics. Nanobodies are a promising tool for the treatment and diagnosis of infectious diseases due to their unique recognition properties. In this study, we report the design of a nanobody-based magnetofluorescent immunoassay for the sensitive detection of pathogenic Escherichia coli F17-positive strains (E. coli F17). For this, a camel was immunized with purified F17A protein from F17 fimbriae and a nanobody library was constructed by phage display. Two specific anti-F17A nanobodies (Nbs) were selected to design the bioassay. The first one (Nb1) was conjugated to magnetic beads (MBs) to form a complex capable of efficiently capturing the target bacteria. A second horseradish peroxidase (HRP)-conjugated nanobody (Nb4) was used for detection by oxidizing o-phenylenediamine (OPD) to fluorescent 2,3-diaminophenazine (DAP). Our results show that the immunoassay recognizes E. coli F17 with high specificity and sensitivity, with a detection limit of 1.8 CFU/mL in only 90 min. Furthermore, we showed that the immunoassay can be applied to fecal samples without pretreatment and remains stable for at least one month when stored at 4 °C.

Keywords